Product Information
Name:SR9011
Controlled Product
Brand:Biosynth
Description:SR9011 is a small-molecule drug that has been shown to have anti-cancer effects. It is currently undergoing clinical trials for the treatment of cancer, including glioblastoma (brain cancer) and non-small cell lung cancer. SR9011 inhibits the activation of microglia cells in the brain, which are associated with neurological disorders such as Alzheimer's disease and Parkinson's disease. This drug also reduces skin inflammation and can be used to treat inflammatory diseases such as Crohn's disease or ulcerative colitis. SR9011 can also be used to treat metabolic disorders, such as type 2 diabetes or obesity. The mechanism of action for SR9011 is not fully understood, but it has been shown to activate autophagy in human liver cells and beta-cells in the pancreas.SR9011 was originally developed by Sirtris Pharmaceuticals under the code name "SR9009."
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:479.04 g/mol
Formula:C23H31ClN4O3S
Purity:Min. 95%
Technical inquiry about: SR9011
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.